ALK-Activating Homologous Mutations in LTK Induce Cellular TransformationJ. Devon Roll, Gary W. Reuther|PLoS ONE|2012Cited by 39
The PIM inhibitor AZD1208 synergizes with ruxolitinib to induce apoptosis of ruxolitinib sensitive and resistant JAK2-V617F-driven cells and inhibit colony formation of primary MPN cellsLucia Mazzacurati, Gary W. Reuther|Oncotarget|2015Cited by 38
Activation of JAK2-V617F by Components of Heterodimeric Cytokine ReceptorsAnuradha Pradhan, Gary W. Reuther|Journal of Biological Chemistry|2010Cited by 30
<scp>SHP2</scp> inhibition displays efficacy as a monotherapy and in combination with <scp>JAK2</scp> inhibition in preclinical models of myeloproliferative neoplasmsGarima Pandey, Gary W. Reuther|American Journal of Hematology|2024Cited by 4